APA (7th ed.) Citation

I, Y., MM, M., AT, T., S, T., ME, S., T, G., . . . A, A. (2018). Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: Impact of optimal cytoreduction and standard adjuvant treatment. International journal of clinical oncology, 23(2), 329. https://doi.org/10.1007/s10147-017-1215-x

Chicago Style (17th ed.) Citation

I, Yalcin, Meydanli MM, Turan AT, Taskin S, Sari ME, Gungor T, Akbayir O, and Ayhan A. "Carcinosarcoma of the Ovary Compared to Ovarian High-grade Serous Carcinoma: Impact of Optimal Cytoreduction and Standard Adjuvant Treatment." International Journal of Clinical Oncology 23, no. 2 (2018): 329. https://doi.org/10.1007/s10147-017-1215-x.

MLA (9th ed.) Citation

I, Yalcin, et al. "Carcinosarcoma of the Ovary Compared to Ovarian High-grade Serous Carcinoma: Impact of Optimal Cytoreduction and Standard Adjuvant Treatment." International Journal of Clinical Oncology, vol. 23, no. 2, 2018, p. 329, https://doi.org/10.1007/s10147-017-1215-x.